Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
OtherMinireview

Interplay between Non-coding RNAs and NRF2 in Different Cancers: Spotlight on miRNAs and Long non-coding RNAs

İlhan Yaylim, Ammad Ahmad Farooqi, Pelin Telkoparan-Akillilar and Luciano Saso
Journal of Pharmacology and Experimental Therapeutics June 6, 2022, JPET-MR-2021-000921; DOI: https://doi.org/10.1124/jpet.121.000921
İlhan Yaylim
1Molecular Medicine, Istanbul University Aziz Sancar Institıte of Experimental Medicine, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: iyaylim@istanbul.edu.tr
Ammad Ahmad Farooqi
2Department of Molecular Oncology, Institute of Biomedical and Genetic Engineering (IBGE), Pakistan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ammad Ahmad Farooqi
Pelin Telkoparan-Akillilar
3Department of Medical Biology, Faculty of Medicine, Yuksek Ihtisas University, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luciano Saso
4Department of Physiology and Pharmacology, Sapienza University of Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

JPET-MR-2021-000921
DOI 
https://doi.org/10.1124/jpet.121.000921
PubMed 
35667688

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Published online June 6, 2022.

Article Versions

  • You are currently viewing an Earlier version of this article (June 6, 2022 - 01:40).
  • View the most recent version of this article
Copyright & Usage 
Copyright © 2020 American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. İlhan Yaylim1,*,
  2. Ammad Ahmad Farooqi2,
  3. Pelin Telkoparan-Akillilar3, and
  4. Luciano Saso4
  1. 1Molecular Medicine, Istanbul University Aziz Sancar Institıte of Experimental Medicine, Turkey
  2. 2Department of Molecular Oncology, Institute of Biomedical and Genetic Engineering (IBGE), Pakistan
  3. 3Department of Medical Biology, Faculty of Medicine, Yuksek Ihtisas University, Turkey
  4. 4Department of Physiology and Pharmacology, Sapienza University of Rome, Italy
  1. ↵* Corresponding Author:
    İlhan Yaylim, Molecular Medicine, Istanbul University Aziz Sancar Institıte of Experimental Medicine, Istanbul, N/A, Turkey. E-mail: iyaylim{at}istanbul.edu.tr

Statistics from Altmetric.com

Article usage

Article usage: June 2022 to March 2023

AbstractFullPdf
Jun 2022306099
Jul 2022257037
Aug 202283021
Sep 202248024
Oct 202251017
Nov 202233015
Dec 2022161819
Jan 20238410668
Feb 2023265354
Mar 2023131720

Next
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 385 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 385, Issue 1
1 Apr 2023
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Interplay between Non-coding RNAs and NRF2 in Different Cancers: Spotlight on miRNAs and Long non-coding RNAs
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
OtherMinireview

Non-coding RNAs and NRF2 in Different Cancers

İlhan Yaylim, Ammad Ahmad Farooqi, Pelin Telkoparan-Akillilar and Luciano Saso
Journal of Pharmacology and Experimental Therapeutics June 6, 2022, JPET-MR-2021-000921; DOI: https://doi.org/10.1124/jpet.121.000921

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
OtherMinireview

Non-coding RNAs and NRF2 in Different Cancers

İlhan Yaylim, Ammad Ahmad Farooqi, Pelin Telkoparan-Akillilar and Luciano Saso
Journal of Pharmacology and Experimental Therapeutics June 6, 2022, JPET-MR-2021-000921; DOI: https://doi.org/10.1124/jpet.121.000921
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Cognitive distortion in atopic dermatitis
  • Traumatic Brain Injury Pharmacology Trials
  • Generic Substitution of Antiseizure Medications
Show more Minireview

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics